This National Cancer Institute (NCI) grant provides administrative supplements for collaborative cancer disparity research. Its purpose is to engage new investigators and partner experienced researchers with cancer disparity specialists to accelerate multi-disciplinary studies. This funding supports research addressing adverse differences in cancer incidence, mortality, or treatment response among racial/ethnic minorities and underserved populations. Proposals must expand existing parent awards to include a cancer disparity component, potentially with international cohorts, within the original scope. This trans-NCI effort, supported by multiple NCI divisions, aims to significantly reduce cancer health inequities.
Opportunity ID: 338351
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-22-114 |
| Funding Opportunity Title: | Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 25, 2022 |
| Last Updated Date: | Feb 25, 2022 |
| Original Closing Date for Applications: | Jan 23, 2025 |
| Current Closing Date for Applications: | Jan 23, 2025 |
| Archive Date: | Feb 28, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Public and State controlled institutions of higher education For profit organizations other than small businesses Independent school districts Special district governments Native American tribal governments (Federally recognized) Private institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. This FOA is intended to accelerate and strengthen multi-disciplinary cancer disparities research in wide ranging areas. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden and/or response to treatment in racial/ethnic minorities and/or underserved population groups. Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets. Importantly, the supplemental request is required to be within the scope of the parent award and should expand the original aims to include a cancer disparity component and possible inclusion of international comparator cohorts. A trans NCI effort, the concept reissuance of the Collaborative Program is supported by NCIs Division of Cancer Biology (DCB), Division of Cancer Treatment and Diagnosis (DCTD), Division of Cancer Prevention (DCP), Division of Cancer Control and Population Sciences (DCCPS), Center to Reduce Cancer Health Disparities (CRCHD) and now, also included Center for Global Health. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-22-114.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G-ADMINSUPP-RESEARCH-REVISED | Use for due dates on or before January 24, 2023 | PKG00276468 | Aug 19, 2022 | Jan 24, 2023 | View | |
| FORMS-H-ADMINSUPP-RESEARCH-REVISED | Use for due dates on or before January 24, 2025 | PKG00278582 | Aug 19, 2022 | Jan 24, 2025 | View |
Package 1
Mandatory forms
338351 RR_SF424_5_0-5.0.pdf
338351 PHS398_CoverPageSupplement_5_0-5.0.pdf
338351 RR_OtherProjectInfo_1_4-1.4.pdf
338351 PerformanceSite_4_0-4.0.pdf
338351 RR_KeyPersonExpanded_4_0-4.0.pdf
338351 PHS398_ResearchPlan_4_0-4.0.pdf
338351 RR_Budget10_3_0-3.0.pdf
Optional forms
338351 RR_SubawardBudget10_30_3_0-3.0.pdf
338351 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Package 2
Mandatory forms
338351 RR_SF424_5_0-5.0.pdf
338351 PHS398_CoverPageSupplement_5_0-5.0.pdf
338351 RR_OtherProjectInfo_1_4-1.4.pdf
338351 PerformanceSite_4_0-4.0.pdf
338351 RR_KeyPersonExpanded_4_0-4.0.pdf
338351 PHS398_ResearchPlan_5_0-5.0.pdf
338351 RR_Budget10_3_0-3.0.pdf
Optional forms
338351 RR_SubawardBudget10_30_3_0-3.0.pdf
338351 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
